Ingevity Corp Files 8-K: Material Agreement, Financials
Ticker: NGVT · Form: 8-K · Filed: 2025-09-04T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, 8-k, financials
Related Tickers: NGVT
TL;DR
INGEVITY CORP (NGVT) FILED AN 8-K ON 9/3/25 FOR A MATERIAL AGREEMENT. CHECK IT OUT.
AI Summary
On September 3, 2025, Ingevity Corporation entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosures and Financial Statements and Exhibits. The company is incorporated in Delaware and headquartered in North Charleston, South Carolina.
Why It Matters
This 8-K filing indicates a significant new agreement for Ingevity Corporation, which could impact its financial performance and strategic direction.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- North Charleston, South Carolina (location) — Principal executive offices location
- September 3, 2025 (date) — Date of report
FAQ
What is the nature of the Material Definitive Agreement filed by Ingevity Corporation?
The filing indicates the entry into a Material Definitive Agreement, but the specific details of the agreement are not provided in the provided text.
When was this 8-K report filed?
The report was filed on September 4, 2025, and the date of the earliest event reported is September 3, 2025.
What are the principal executive offices of Ingevity Corporation?
The principal executive offices are located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina, 29405.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Ingevity Corporation's Standard Industrial Classification code?
Ingevity Corporation's Standard Industrial Classification code is 2800, which falls under CHEMICALS & ALLIED PRODUCTS.
Filing Stats: 2,667 words · 11 min read · ~9 pages · Grade level 20 · Accepted 2025-09-04 06:45:01
Key Financial Figures
- $0.01 — e on which registered Common Stock ($0.01 par value) NGVT New York Stock Exch
- $110 million — ice for the Transaction will consist of $110 million in cash, subject to customary adjustmen
- $19 million — onal, contingent consideration of up to $19 million based on the highest EBITDA amount earn
- $5 million — e obligated to pay a termination fee of $5 million to the non-breaching party. Further, In
- $7.5 million — e obligated to pay a termination fee of $7.5 million in the event Purchaser terminates the P
- $520,000 — urchaser a termination diligence fee of $520,000 upon termination of the Purchase Agreem
- $7,500,000 — mination fee payable by Ingevity exceed $7,500,000, which will be payable in addition to s
Filing Documents
- form8-k.htm (8-K) — 68KB
- ex2-1.htm (EX-2.1) — 723KB
- ex99-1.htm (EX-99.1) — 30KB
- form8-k_001.jpg (GRAPHIC) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-012603.txt ( ) — 1134KB
- ngvt-20250903.xsd (EX-101.SCH) — 3KB
- ngvt-20250903_lab.xml (EX-101.LAB) — 33KB
- ngvt-20250903_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) Date: September 4, 2025 By: /s/ Mary Dean Hall Mary Dean Hall Executive Vice President and Chief Financial Officer